Top Markets
#1 Seeker Seeker +133.86%
#2 AI XOVIA AI XOVIA +102.03%
#3 Helium Helium +70.79%
#4 MowCat MowCat +68.76%
#5 Pons Pons +40.10%
#6 UnifAI Network UnifAI Network +34.88%
#7 Zora Zora +31.89%
#8 Zylo Ecosystem Zylo Ecosystem +20.92%
#9 Bounce Bounce +20.57%
#10 TENDIES TENDIES +19.28%
Coin of the day
Seeker Seeker
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
OmniAb, Inc. OmniAb, Inc.

OmniAb, Inc.

OABI
Classifica tra le azioni #11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Prezzo delle azioni
$4.48
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$649.33M
Variazione (1 giorno)
-2.84%
Variazione (1 anno)
179.94%
Paese
US
Scambia OmniAb, Inc. (OABI)

Categoria

Healthcare
Ricavi di OmniAb, Inc. (OABI)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di OmniAb, Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per OmniAb, Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH